TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
QIAGEN DNA Synthesis AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
12,535
|
9,019
|
7,050 |
| Financial expenses |
644
|
806
|
446 |
| Earnings before taxes |
-227
|
-3,570
|
-4,781 |
| EBITDA |
1,397
|
-1,786
|
-3,614 |
| Total assets |
13,145
|
15,191
|
14,335 |
| Current assets |
6,437
|
7,800
|
8,074 |
| Current liabilities |
10,164
|
11,869
|
12,630 |
| Equity capital |
2,981
|
3,322
|
1,705 |
| - share capital |
17
|
18
|
18 |
| Employees (average) |
90
|
99
|
105 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
22.7%
|
21.9%
|
11.9% |
| Turnover per employee |
139
|
91
|
67 |
| Profit as a percentage of turnover |
-1.8%
|
-39.6%
|
-67.8% |
| Return on assets (ROA) |
3.2%
|
-18.2%
|
-30.2% |
| Current ratio |
63.3%
|
65.7%
|
63.9% |
| Return on equity (ROE) |
-7.6%
|
-107.5%
|
-280.4% |
| Change turnover |
3,822
|
1,948
|
-637 |
| Change turnover % |
44%
|
28%
|
-8% |
| Chg. No. of employees |
-9
|
-6
|
8 |
| Chg. No. of employees % |
-9%
|
-6%
|
8% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.